Clinical Trial Update: Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DAC combined with the HAAG regimen in newly diagnosed younger patients with acute myeloid leukemia undergoing induction chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DAC
• HAAG regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Induction Chemotherapy | Phase 3 | Status: UNKNOWN